Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insights

Set Alert for Digital Health

Minute Insight: Dutch Grant Funds Antibiotic Resistance Test

SoundCell BV and Applied Nanolayers are using genetically engineered E.Coli contained in a graphene chip to test for antibiotic resistance.

Minute Insights Diagnostics

Minute Insight: Theranica’s Wearable Earns Expanded FDA Clearance For Preventing Migraines

Theranica’s expanded US FDA clearance allows the company to market its prescription-based wearable as both an acute and preventive treatment for migraine headaches.

Minute Insights Digital Health

Minute Insight: Vytalize Raises $100M To Advance Value-Based Care For Seniors

After raising $50m in a series B funding round last April, value-based care platform Vytalize has raised another $100m to build out its clinical support platform for primary care doctors.

Minute Insights Commercial

Minute Insight: Medtronic Relaunches Harmony Pulmonary Valve Replacement

The company pulled Harmony from the market about a year ago following six reports of the capsule at the end of its delivery catheter breaking.

Minute Insights Recalls

Minute Insight: Medtronic’s Extravascular ICD Earns European Approval

The Aurora extravascular implantable cardioverter defibrillator and the Epsila extravascular lead earned a CE mark supported by results from a global pivotal study.

Minute Insights Clinical Trials

Minute Insight: Insulet Acquires Insulin Pump Patents From Bigfoot, AGC

Insulet will acquire insulin pump patents from Bigfoot Biomedical for $25m, which Bigfoot will use to expand its Unity diabetes management system. Insulet also announced the acquisition of automated insulin delivery assets held by Automated Glucose Control.

Minute Insights Intellectual Property

Minute Insight: J&J Monarch Robot Removes Kidney Stone With Mini-PCNL Procedure

The company is sponsoring the first clinical study of robotically assisted electromagnetic-guided percutaneous access and mini-percutaneous nephrolithotomy – kidney stone removal – with the Monarch robotic-assisted platform for urology.

Minute Insights Clinical Trials

Minute Insight: Abbott Wins Expanded FDA Approval For Proclaim XR Spinal Cord Stimulator For Diabetic Peripheral Neuropathy

Abbott said a major competitive benefit of the Proclaim XR SCS system is the battery life of up to 10 years at low settings.

Minute Insights Approvals
See All
UsernamePublicRestriction

Register